Insertable Cardiac Monitoring System
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Insertable Cardiac Monitoring System
The Reveal LINQ™ Insertable Cardiac Monitor is a wireless, powerfully small insertable cardiac monitor, ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management.
World’s Smallest ICM1
One-third the size of a AAA battery (1.2 cc)
Device longevity that optimizes diagnostic yield
World’s Most Accurate ICM Algorithm2
TruRhythm™ Detection inside Reveal LINQ™ ICM
1.5T & 3T MRI Conditional
No post-insertion wait time or patient positioning restrictions**
700+ PUBLISHED CLINICAL ARTICLES & ABSTRACTS
Evidence portfolio3 for RevealTM Family of ICMs
*Reference the Reveal LINQ ICM Clinician Manual for usage parameters.
**Reveal LINQ has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use. Please see the Reveal LINQ MRI Technical Manual for more details.
Earlier use of the Reveal LINQ™ ICM increases diagnostic yield versus standard of care, whilst reducing hospitalisations, injuries, and costs associated with Syncope patients.4,5
ESC 2018 SYNCOPE GUIDELINES
Highest recommendation and evidence for early ICM monitoring for patients with high arrhythmia risk or recurrent symptoms more than 30 days apart.4
Additional ECG monitoring by long-term non-invasive ECG monitors or ICMs should be considered to document silent AF and prevent secondary stroke.7
REVEAL LINQ™ OUT-OF-THE-LAB PROCEDURE
Reveal LINQ™ has extensive evidence to support out-of–lab insertion being feasible, safe and efficient.9-21
Moving the procedure out of lab:
REVEAL LINQ™ MOBILE MANAGER
Reveal LINQ™ Mobile Manager is a tablet based programmer which enables seamless
out-of-lab procedure, with integrated device programming and remote monitoring enrollment capabilities.
Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.
*Based on AF episodes ≥ 2 minutes and in known AF patients. % of false positives = (1 – episode PPV). AF episodes PPV may vary between gross and patient average.
†Confirm™ Rx with SharpSense™ technology & BIOMONITOR III have no published clinical evidence showing AF episode PPV or AF sensitivity.
When compared to other ICMs, Reveal LINQ™ with TruRhythm™ Detection provides up to:22, 26
In a known AF patient population. % Full-time Employee 100 Patient Clinic, 40 hours per week, 44 weeks/year.
Exclusive app-based programmer that simplifies ICM procedure, enabling device activation, programming and CareLink™ pre-enrollment, all from your tablet.
World’s smallest1 and most accurate2 ICM, enabling diagnosis even for the most difficult-to detect arrhythmias.
Easy-to-use remote patient monitor with international coverage. Keeps you seamlessly connected to your patients.
Phone support service dedicated to patients. Frees up clinic time as patients can contact us when they have device or monitoring questions
Patient monitoring network that enables data-driven care decisions, quickly and easily.
Triaging Service saves time and enables better outcomes by triaging all CareLink™ data and promptly alerting your clinical team to the 20% of data that requires action.27,28
BECONNECTED PATIENT SERVICE
BeConnected is a patient support service designed to free up clinic time by directing patients to our experienced team to answer device and monitoring questions.
FOCUSON™ MONITORING AND TRIAGING SERVICE
FocusOn™ operates as a virtual extension of your team. Staffed with certified ECG device specialists and cardiologists, FocusOn™ reduces time spent reviewing non-actionable data, so that hospital clinical teams can focus on what matters.
*For patients implanted with Reveal LINQTM ICM - based on 11.4 minutes per transmission.28, 30, 31
ICM Size Comparison Guide. Medtronic data on file. 2019.
ICM Published Accuracy Comparison Guide. 2019.
Medtronic Reveal™ Publications. Medtronic data on file. 2019.
Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. June 1, 2018;39(21):1883-1948.
Wolff P. Long Term Clinical and Economic Burden of Recurrent Unexplained Syncope and the Real World Effectiveness of Insertable Cardiac Monitors in England. Presented at ESC 2016.
Tsivgoulis G, et al. Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke. Published online June 20, 2019.
Kirchhof P, Benussi S, Kotecha D, et al. “2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.” EurHeart J.October 7, 2016;37(38):2893-2962.
Kolominsky-Rabas PL, Heuschmann PU, Marschall D, et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry. Stroke. May 2006;37(5): 1179-1183.
Roebuck, A., et al. BJC 22 (2015).
BHRS Standards for insertion, follow up and explant of implantable loop recorders [ILRs] by non-medical staff, 2018.
Di Odoardo LAF, et al. J Cardiovasc Med. 2017;18:550-552.
Kipp R, et al.PACE. 2017;40:982-985.
Kanters, Tim A., et al. Europace (2015): euv217.
Wong GR, et al. Int J Cardiol. 2016;223:13-17.
Mittal S, et al. PACE. 2015; 38:1464-1469.
Beinart SC, et al. Heart Rhythm. 2016;13:5 SUPPL 1 (S15).
Sanders P, et al. JACC. 2017;69:354.
Diederichsen SZ, et al. Int J Cardiol. 2017;241:229-234.
Maines M et al. Europace. 2017;doi:10.1093/europace/eux187.
Rogers JD, et al. Heart Rhythm. 2017;14:218-224.
Rogers, John D., et al. Journal of Medical Economics (2020): 1-8.
Pürerfellner H, et al. Europace. 2018;20:f321-f328.
Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.
Nölker G, et al. J Cardiovasc Electrophysiol. 2016;27:1403-1410.
Biotronik BioMonitor 2 Technical Manual. 2017.
Rosemas S. AF Algorithm Clinic Efficiency. Medtronic data on file. April 2020. Based on Rogers J., et al. Circulation 140: A11947, Nölker 2016, Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017, Biotronik BioMonitor™ 2 Technical Manual 2017. Pürerfellner 2018.
Cronin et al, 2012, Heart Rhythm, vol 9, n°12.
Medtronic Data on File.
Drak-Hernández Y et al. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed). 2013;66(12):943-8.
Guédon-Moreau L et al. 2015;8(4):403-12.
CareLink Express Pilot Study in Europe, Medtronic Data on File 2013.